Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation

Gastroenterology

Volumn 107, Issue 4, 1994, Pages 1050-1058

  Davenpeck, Kelly L ^a   Gauthier, Theresa W ^b   Lefer, Allan M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC GMP; ARGININE; DEXTRO ARGININE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PB1.3; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PADGEM PROTEIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTESTINE BLOOD FLOW; LEUKOCYTE ADHERENCE; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VENULE;

EID: 0028128957     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(94)90229-1     Document Type: Article

References (39)

1. Endothelium-derived nitric oxide: actions and properties
2. Nitric oxide modulates microvascular permeability
3. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat
4. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium
5. Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis
6. Inhibition of nitric oxide production; mechanisms of vascular albumin leakage
7. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140
8. GMP-140, a receptor that mediates interactions of leukocytes with activated platelets and endothelium
9. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies
10. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils
11. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils
12. Role of P-selectin in microvasculature leukocyte and endothelial interaction in splanchnic ischemia-reperfusion
13. Neutrophil-dependent acute lung injury; requirement for P-selectin (GMP-140)
14. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury
15. Anti-P-selectin monoclonal antibody attenuates reperfusion injury in rabbit ear
16. Nitric oxide attenuates leukocyte and endothelial interaction via P-selectin in splanchnic ischemia-reperfusion
17. An optical doppler intravital velocimeter
18. Leukocyte adherence to venular endothelium during ischemia-reperfusion
19. Immunohistochemical localization of membrane and α-granule proteins in human megakaryocytes: application to plastic embedded bone marrow biopsy specimens
20. Nitric oxide: an endogenous modulator of leukocyte adhesion
21. Nitric oxide: physiology, pathophysiology, and pharmacology
22. Cardiac venous endothelial dysfunction after myocardial ischemia and reperfusion in dogs
23. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells
24. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide
25. 2-adrenoceptors and endothelium-derived relaxing factor
26. Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies
27. EDRF from rat intestine and skeletal muscle venules cause dilation of arterioles
28. PMN adherence to cat ischemic-reperfused mesenteric vascular endothelium under flow: role of P-selectin
29. Pharmacology of the endothelium in ischemiareperfusion and circulatory shock
30. EDRF-a protective factor?
31. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock
32. Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion
33. Nitric oxide synthesis inhibition induces leukocyte adhesion via Superoxide and mast cells
34. Metabolic sources of reactive oxygen metabolites during oxidant stress and ischemia and reperfusion
35. Cytoprotective function of nitric oxide: inactivation of Superoxide radicals produced by human leukocytes
36. Molecular mechanisms involved in superoxide-induced leukocyte and endothelial cell interactions in vivo
37. 2-analogues and an NO (EDRF)-donor: a comparison between platelets of healthy subjects and diabetic subjects
38. Inhibition of platelet functions by a monoclonal antibody (LYP20) directed against a granule membrane glycoprotein (GMP-140, PADGEM)
39. Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells